Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

BLX ?5.0 WB, SLActive? 14mm, RXD: medical device reports filed with FDA

379 reports name it, 2019–2026. Manufacturer given most often on reports: Institut Straumann. Product code DZE.

379
device reports naming the brand
0% of all MAUDE reports · about 55 a year
80
reports, 12 months to August 2026
67 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 379 reports that name the brand "BLX ?5.0 WB, SLActive? 14mm, RXD" (endosseous dental implant), received between August 2019 and August 2026; the manufacturer given most often on reports is Institut Straumann. Spellings of one product vary from report to report.

80 reports arrived in the 12 months to August 2026, up 19% from 67 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (59.4%), loss of osseointegration (11.9%) and difficult to insert (2.6%). The patient problems coded most often are fibrosis, pain and hyperresponsive to stimuli. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

01019Sep 2021: 2Oct 2021: 5Nov 2021: 9Dec 2021: 32022Jan 2022: 3Feb 2022: 2Mar 2022: 0Apr 2022: 2May 2022: 7Jun 2022: 2Jul 2022: 2Aug 2022: 2Sep 2022: 3Oct 2022: 5Nov 2022: 5Dec 2022: 62023Jan 2023: 0Feb 2023: 3Mar 2023: 6Apr 2023: 5May 2023: 10Jun 2023: 4Jul 2023: 6Aug 2023: 13Sep 2023: 11Oct 2023: 7Nov 2023: 8Dec 2023: 72024Jan 2024: 3Feb 2024: 2Mar 2024: 6Apr 2024: 7May 2024: 3Jun 2024: 5Jul 2024: 3Aug 2024: 9Sep 2024: 10Oct 2024: 7Nov 2024: 4Dec 2024: 62025Jan 2025: 5Feb 2025: 2Mar 2025: 6Apr 2025: 2May 2025: 0Jun 2025: 19Jul 2025: 4Aug 2025: 2Sep 2025: 10Oct 2025: 5Nov 2025: 5Dec 2025: 72026Jan 2026: 0Feb 2026: 5Mar 2026: 10Apr 2026: 8May 2026: 0Jun 2026: 6Jul 2026: 12Aug 2026: 12

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

040802019: 420192020: 2320202021: 4820212022: 3920222023: 8020232024: 6520242025: 6720252026: 532026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%379
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report64.4%244
Voluntary report0%0
User facility report0%0
Distributor report35.6%135
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate22559.4%62.8%
Loss of osseointegration4511.9%22.4%
Difficult to insertthe device was hard to insert102.6%0.4%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Fibrosis9825.9%
Painpain, site not specified6015.8%
Hyperresponsive to stimuli184.7%
Inflammationinflammation143.7%
Tissue damage123.2%
Hemorrhage/blood loss/bleeding92.4%
Numbnessnumbness82.1%
Hypersensitivity/allergic reaction61.6%
Swelling/ edema51.3%
Fistula30.8%
Abscessa collection of pus20.5%
Failure of implant20.5%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureBLX ?5.0 WB, SLActive? 14mm, RXDProduct code DZEAll MAUDE reports
Reports3793,924,24126,136,888
Share of that pool—0%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer64.4%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about BLX ?5.0 WB, SLActive? 14mm, RXD reports

How many FDA reports name BLX ?5.0 WB, SLActive? 14mm, RXD?

379 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 80 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (59.4%), loss of osseointegration (11.9%) and difficult to insert (2.6%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (64.4%) and distributor reports (35.6%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that BLX ?5.0 WB, SLActive? 14mm, RXD was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.